Functional gum market sees GLP-1 boost
The functional chewing gum market is growing, partly due to a 25% increase in gum purchases by GLP-1 (Ozempic) users managing medication side effects.
GLP-1 drugs can cause side effects like dry mouth and bad breath due to reduced saliva production, creating an environment for bacteria to thrive. This has led to the term "Ozempic breath". Functional chewing gum can help alleviate these issues by stimulating saliva flow. Some gums include ingredients like xylitol, probiotics, zinc, and tannins to combat bad breath and improve oral health. The functional chewing gum market is experiencing growth, with projections estimating it will reach USD 42.6 billion by 2035. This growth is driven by consumers seeking convenient ways to improve wellness and address specific health concerns. Beyond oral health, research suggests chewing sugarless gum may increase satiety and help control energy intake. Studies indicate that chewing gum can also increase GLP-1 secretion, which may further aid in weight management.
